Talk about urology

Назад к списку

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial

https://www.europeanurology.com/article/S0302-2838(21)02217-X/fulltext